Table of Content

1 Chronic Urticaria Or Hives Drug Market Overview
1.1 Product Overview and Scope of Chronic Urticaria Or Hives Drug
1.2 Chronic Urticaria Or Hives Drug Segment by Type
1.2.1 Global Chronic Urticaria Or Hives Drug Market Value Comparison by Type (2024-2034)
1.2.2 GDC-0853
1.2.3 GSK-2646264
1.2.4 BF-Derm-1
1.2.5 Bilastine
1.2.6 Others
1.3 Chronic Urticaria Or Hives Drug Segment by Application
1.3.1 Global Chronic Urticaria Or Hives Drug Market Value by Application: (2024-2034)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global Chronic Urticaria Or Hives Drug Market Size Estimates and Forecasts
1.4.1 Global Chronic Urticaria Or Hives Drug Revenue 2018-2034
1.4.2 Global Chronic Urticaria Or Hives Drug Sales 2018-2034
1.4.3 Global Chronic Urticaria Or Hives Drug Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Chronic Urticaria Or Hives Drug Market Competition by Manufacturers
2.1 Global Chronic Urticaria Or Hives Drug Sales Market Share by Manufacturers (2018-2024)
2.2 Global Chronic Urticaria Or Hives Drug Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Chronic Urticaria Or Hives Drug Average Price by Manufacturers (2018-2024)
2.4 Global Chronic Urticaria Or Hives Drug Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Chronic Urticaria Or Hives Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Chronic Urticaria Or Hives Drug, Product Type & Application
2.7 Chronic Urticaria Or Hives Drug Market Competitive Situation and Trends
2.7.1 Chronic Urticaria Or Hives Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Chronic Urticaria Or Hives Drug Players Market Share by Revenue
2.7.3 Global Chronic Urticaria Or Hives Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Chronic Urticaria Or Hives Drug Retrospective Market Scenario by Region
3.1 Global Chronic Urticaria Or Hives Drug Market Size by Region: 2018 Versus 2022 Versus 2034
3.2 Global Chronic Urticaria Or Hives Drug Global Chronic Urticaria Or Hives Drug Sales by Region: 2018-2034
3.2.1 Global Chronic Urticaria Or Hives Drug Sales by Region: 2018-2024
3.2.2 Global Chronic Urticaria Or Hives Drug Sales by Region: 2024-2034
3.3 Global Chronic Urticaria Or Hives Drug Global Chronic Urticaria Or Hives Drug Revenue by Region: 2018-2034
3.3.1 Global Chronic Urticaria Or Hives Drug Revenue by Region: 2018-2024
3.3.2 Global Chronic Urticaria Or Hives Drug Revenue by Region: 2024-2034
3.4 North America Chronic Urticaria Or Hives Drug Market Facts & Figures by Country
3.4.1 North America Chronic Urticaria Or Hives Drug Market Size by Country: 2018 VS 2022 VS 2034
3.4.2 North America Chronic Urticaria Or Hives Drug Sales by Country (2018-2034)
3.4.3 North America Chronic Urticaria Or Hives Drug Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Chronic Urticaria Or Hives Drug Market Facts & Figures by Country
3.5.1 Europe Chronic Urticaria Or Hives Drug Market Size by Country: 2018 VS 2022 VS 2034
3.5.2 Europe Chronic Urticaria Or Hives Drug Sales by Country (2018-2034)
3.5.3 Europe Chronic Urticaria Or Hives Drug Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Chronic Urticaria Or Hives Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Chronic Urticaria Or Hives Drug Market Size by Country: 2018 VS 2022 VS 2034
3.6.2 Asia Pacific Chronic Urticaria Or Hives Drug Sales by Country (2018-2034)
3.6.3 Asia Pacific Chronic Urticaria Or Hives Drug Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Chronic Urticaria Or Hives Drug Market Facts & Figures by Country
3.7.1 Latin America Chronic Urticaria Or Hives Drug Market Size by Country: 2018 VS 2022 VS 2034
3.7.2 Latin America Chronic Urticaria Or Hives Drug Sales by Country (2018-2034)
3.7.3 Latin America Chronic Urticaria Or Hives Drug Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Chronic Urticaria Or Hives Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Chronic Urticaria Or Hives Drug Market Size by Country: 2018 VS 2022 VS 2034
3.8.2 Middle East and Africa Chronic Urticaria Or Hives Drug Sales by Country (2018-2034)
3.8.3 Middle East and Africa Chronic Urticaria Or Hives Drug Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Chronic Urticaria Or Hives Drug Sales by Type (2018-2034)
4.1.1 Global Chronic Urticaria Or Hives Drug Sales by Type (2018-2024)
4.1.2 Global Chronic Urticaria Or Hives Drug Sales by Type (2024-2034)
4.1.3 Global Chronic Urticaria Or Hives Drug Sales Market Share by Type (2018-2034)
4.2 Global Chronic Urticaria Or Hives Drug Revenue by Type (2018-2034)
4.2.1 Global Chronic Urticaria Or Hives Drug Revenue by Type (2018-2024)
4.2.2 Global Chronic Urticaria Or Hives Drug Revenue by Type (2024-2034)
4.2.3 Global Chronic Urticaria Or Hives Drug Revenue Market Share by Type (2018-2034)
4.3 Global Chronic Urticaria Or Hives Drug Price by Type (2018-2034)
5 Segment by Application
5.1 Global Chronic Urticaria Or Hives Drug Sales by Application (2018-2034)
5.1.1 Global Chronic Urticaria Or Hives Drug Sales by Application (2018-2024)
5.1.2 Global Chronic Urticaria Or Hives Drug Sales by Application (2024-2034)
5.1.3 Global Chronic Urticaria Or Hives Drug Sales Market Share by Application (2018-2034)
5.2 Global Chronic Urticaria Or Hives Drug Revenue by Application (2018-2034)
5.2.1 Global Chronic Urticaria Or Hives Drug Revenue by Application (2018-2024)
5.2.2 Global Chronic Urticaria Or Hives Drug Revenue by Application (2024-2034)
5.2.3 Global Chronic Urticaria Or Hives Drug Revenue Market Share by Application (2018-2034)
5.3 Global Chronic Urticaria Or Hives Drug Price by Application (2018-2034)
6 Key Companies Profiled
6.1 AstraZeneca Plc
6.1.1 AstraZeneca Plc Corporation Information
6.1.2 AstraZeneca Plc Description and Business Overview
6.1.3 AstraZeneca Plc Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2018-2024)
6.1.4 AstraZeneca Plc Chronic Urticaria Or Hives Drug Product Portfolio
6.1.5 AstraZeneca Plc Recent Developments/Updates
6.2 Biofrontera AG
6.2.1 Biofrontera AG Corporation Information
6.2.2 Biofrontera AG Description and Business Overview
6.2.3 Biofrontera AG Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Biofrontera AG Chronic Urticaria Or Hives Drug Product Portfolio
6.2.5 Biofrontera AG Recent Developments/Updates
6.3 ELORAC, Inc.
6.3.1 ELORAC, Inc. Corporation Information
6.3.2 ELORAC, Inc. Description and Business Overview
6.3.3 ELORAC, Inc. Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2018-2024)
6.3.4 ELORAC, Inc. Chronic Urticaria Or Hives Drug Product Portfolio
6.3.5 ELORAC, Inc. Recent Developments/Updates
6.4 Faes Farma, SA
6.4.1 Faes Farma, SA Corporation Information
6.4.2 Faes Farma, SA Description and Business Overview
6.4.3 Faes Farma, SA Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Faes Farma, SA Chronic Urticaria Or Hives Drug Product Portfolio
6.4.5 Faes Farma, SA Recent Developments/Updates
6.5 Genentech, Inc.
6.5.1 Genentech, Inc. Corporation Information
6.5.2 Genentech, Inc. Description and Business Overview
6.5.3 Genentech, Inc. Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Genentech, Inc. Chronic Urticaria Or Hives Drug Product Portfolio
6.5.5 Genentech, Inc. Recent Developments/Updates
6.6 GlaxoSmithKline Plc
6.6.1 GlaxoSmithKline Plc Corporation Information
6.6.2 GlaxoSmithKline Plc Description and Business Overview
6.6.3 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2018-2024)
6.6.4 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Product Portfolio
6.6.5 GlaxoSmithKline Plc Recent Developments/Updates
6.7 J Uriach Y Compania, S.A.
6.6.1 J Uriach Y Compania, S.A. Corporation Information
6.6.2 J Uriach Y Compania, S.A. Description and Business Overview
6.6.3 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2018-2024)
6.4.4 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Product Portfolio
6.7.5 J Uriach Y Compania, S.A. Recent Developments/Updates
6.8 Mabtech Limited
6.8.1 Mabtech Limited Corporation Information
6.8.2 Mabtech Limited Description and Business Overview
6.8.3 Mabtech Limited Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Mabtech Limited Chronic Urticaria Or Hives Drug Product Portfolio
6.8.5 Mabtech Limited Recent Developments/Updates
6.9 Merck & Co., Inc.
6.9.1 Merck & Co., Inc. Corporation Information
6.9.2 Merck & Co., Inc. Description and Business Overview
6.9.3 Merck & Co., Inc. Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Merck & Co., Inc. Chronic Urticaria Or Hives Drug Product Portfolio
6.9.5 Merck & Co., Inc. Recent Developments/Updates
6.10 Mycenax Biotech Inc.
6.10.1 Mycenax Biotech Inc. Corporation Information
6.10.2 Mycenax Biotech Inc. Description and Business Overview
6.10.3 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Product Portfolio
6.10.5 Mycenax Biotech Inc. Recent Developments/Updates
6.11 Novartis AG
6.11.1 Novartis AG Corporation Information
6.11.2 Novartis AG Chronic Urticaria Or Hives Drug Description and Business Overview
6.11.3 Novartis AG Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Novartis AG Chronic Urticaria Or Hives Drug Product Portfolio
6.11.5 Novartis AG Recent Developments/Updates
6.12 Panacea Biotec Limited
6.12.1 Panacea Biotec Limited Corporation Information
6.12.2 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Description and Business Overview
6.12.3 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Product Portfolio
6.12.5 Panacea Biotec Limited Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Chronic Urticaria Or Hives Drug Industry Chain Analysis
7.2 Chronic Urticaria Or Hives Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Chronic Urticaria Or Hives Drug Production Mode & Process
7.4 Chronic Urticaria Or Hives Drug Sales and Marketing
7.4.1 Chronic Urticaria Or Hives Drug Sales Channels
7.4.2 Chronic Urticaria Or Hives Drug Distributors
7.5 Chronic Urticaria Or Hives Drug Customers
8 Chronic Urticaria Or Hives Drug Market Dynamics
8.1 Chronic Urticaria Or Hives Drug Industry Trends
8.2 Chronic Urticaria Or Hives Drug Market Drivers
8.3 Chronic Urticaria Or Hives Drug Market Challenges
8.4 Chronic Urticaria Or Hives Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Chronic Urticaria Or Hives Drug Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Chronic Urticaria Or Hives Drug Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Chronic Urticaria Or Hives Drug Market Competitive Situation by Manufacturers in 2022
Table 4. Global Chronic Urticaria Or Hives Drug Sales (K Pcs) of Key Manufacturers (2018-2024)
Table 5. Global Chronic Urticaria Or Hives Drug Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Chronic Urticaria Or Hives Drug Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Chronic Urticaria Or Hives Drug Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Chronic Urticaria Or Hives Drug Average Price (USD/Pcs) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Chronic Urticaria Or Hives Drug, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Chronic Urticaria Or Hives Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Chronic Urticaria Or Hives Drug, Product Type & Application
Table 12. Global Key Manufacturers of Chronic Urticaria Or Hives Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Chronic Urticaria Or Hives Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Urticaria Or Hives Drug as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Chronic Urticaria Or Hives Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 17. Global Chronic Urticaria Or Hives Drug Sales by Region (2018-2024) & (K Pcs)
Table 18. Global Chronic Urticaria Or Hives Drug Sales Market Share by Region (2018-2024)
Table 19. Global Chronic Urticaria Or Hives Drug Sales by Region (2024-2034) & (K Pcs)
Table 20. Global Chronic Urticaria Or Hives Drug Sales Market Share by Region (2024-2034)
Table 21. Global Chronic Urticaria Or Hives Drug Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Region (2018-2024)
Table 23. Global Chronic Urticaria Or Hives Drug Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Region (2024-2034)
Table 25. North America Chronic Urticaria Or Hives Drug Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 26. North America Chronic Urticaria Or Hives Drug Sales by Country (2018-2024) & (K Pcs)
Table 27. North America Chronic Urticaria Or Hives Drug Sales by Country (2024-2034) & (K Pcs)
Table 28. North America Chronic Urticaria Or Hives Drug Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Chronic Urticaria Or Hives Drug Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Chronic Urticaria Or Hives Drug Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Chronic Urticaria Or Hives Drug Sales by Country (2018-2024) & (K Pcs)
Table 32. Europe Chronic Urticaria Or Hives Drug Sales by Country (2024-2034) & (K Pcs)
Table 33. Europe Chronic Urticaria Or Hives Drug Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Chronic Urticaria Or Hives Drug Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Chronic Urticaria Or Hives Drug Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Chronic Urticaria Or Hives Drug Sales by Region (2018-2024) & (K Pcs)
Table 37. Asia Pacific Chronic Urticaria Or Hives Drug Sales by Region (2024-2034) & (K Pcs)
Table 38. Asia Pacific Chronic Urticaria Or Hives Drug Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Chronic Urticaria Or Hives Drug Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Chronic Urticaria Or Hives Drug Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Chronic Urticaria Or Hives Drug Sales by Country (2018-2024) & (K Pcs)
Table 42. Latin America Chronic Urticaria Or Hives Drug Sales by Country (2024-2034) & (K Pcs)
Table 43. Latin America Chronic Urticaria Or Hives Drug Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Chronic Urticaria Or Hives Drug Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Chronic Urticaria Or Hives Drug Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Chronic Urticaria Or Hives Drug Sales by Country (2018-2024) & (K Pcs)
Table 47. Middle East & Africa Chronic Urticaria Or Hives Drug Sales by Country (2024-2034) & (K Pcs)
Table 48. Middle East & Africa Chronic Urticaria Or Hives Drug Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Chronic Urticaria Or Hives Drug Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Chronic Urticaria Or Hives Drug Sales (K Pcs) by Type (2018-2024)
Table 51. Global Chronic Urticaria Or Hives Drug Sales (K Pcs) by Type (2024-2034)
Table 52. Global Chronic Urticaria Or Hives Drug Sales Market Share by Type (2018-2024)
Table 53. Global Chronic Urticaria Or Hives Drug Sales Market Share by Type (2024-2034)
Table 54. Global Chronic Urticaria Or Hives Drug Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Chronic Urticaria Or Hives Drug Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Type (2018-2024)
Table 57. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Type (2024-2034)
Table 58. Global Chronic Urticaria Or Hives Drug Price (USD/Pcs) by Type (2018-2024)
Table 59. Global Chronic Urticaria Or Hives Drug Price (USD/Pcs) by Type (2024-2034)
Table 60. Global Chronic Urticaria Or Hives Drug Sales (K Pcs) by Application (2018-2024)
Table 61. Global Chronic Urticaria Or Hives Drug Sales (K Pcs) by Application (2024-2034)
Table 62. Global Chronic Urticaria Or Hives Drug Sales Market Share by Application (2018-2024)
Table 63. Global Chronic Urticaria Or Hives Drug Sales Market Share by Application (2024-2034)
Table 64. Global Chronic Urticaria Or Hives Drug Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Chronic Urticaria Or Hives Drug Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Application (2018-2024)
Table 67. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Application (2024-2034)
Table 68. Global Chronic Urticaria Or Hives Drug Price (USD/Pcs) by Application (2018-2024)
Table 69. Global Chronic Urticaria Or Hives Drug Price (USD/Pcs) by Application (2024-2034)
Table 70. AstraZeneca Plc Corporation Information
Table 71. AstraZeneca Plc Description and Business Overview
Table 72. AstraZeneca Plc Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 73. AstraZeneca Plc Chronic Urticaria Or Hives Drug Product
Table 74. AstraZeneca Plc Recent Developments/Updates
Table 75. Biofrontera AG Corporation Information
Table 76. Biofrontera AG Description and Business Overview
Table 77. Biofrontera AG Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 78. Biofrontera AG Chronic Urticaria Or Hives Drug Product
Table 79. Biofrontera AG Recent Developments/Updates
Table 80. ELORAC, Inc. Corporation Information
Table 81. ELORAC, Inc. Description and Business Overview
Table 82. ELORAC, Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 83. ELORAC, Inc. Chronic Urticaria Or Hives Drug Product
Table 84. ELORAC, Inc. Recent Developments/Updates
Table 85. Faes Farma, SA Corporation Information
Table 86. Faes Farma, SA Description and Business Overview
Table 87. Faes Farma, SA Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 88. Faes Farma, SA Chronic Urticaria Or Hives Drug Product
Table 89. Faes Farma, SA Recent Developments/Updates
Table 90. Genentech, Inc. Corporation Information
Table 91. Genentech, Inc. Description and Business Overview
Table 92. Genentech, Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 93. Genentech, Inc. Chronic Urticaria Or Hives Drug Product
Table 94. Genentech, Inc. Recent Developments/Updates
Table 95. GlaxoSmithKline Plc Corporation Information
Table 96. GlaxoSmithKline Plc Description and Business Overview
Table 97. GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 98. GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Product
Table 99. GlaxoSmithKline Plc Recent Developments/Updates
Table 100. J Uriach Y Compania, S.A. Corporation Information
Table 101. J Uriach Y Compania, S.A. Description and Business Overview
Table 102. J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 103. J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Product
Table 104. J Uriach Y Compania, S.A. Recent Developments/Updates
Table 105. Mabtech Limited Corporation Information
Table 106. Mabtech Limited Description and Business Overview
Table 107. Mabtech Limited Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 108. Mabtech Limited Chronic Urticaria Or Hives Drug Product
Table 109. Mabtech Limited Recent Developments/Updates
Table 110. Merck & Co., Inc. Corporation Information
Table 111. Merck & Co., Inc. Description and Business Overview
Table 112. Merck & Co., Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 113. Merck & Co., Inc. Chronic Urticaria Or Hives Drug Product
Table 114. Merck & Co., Inc. Recent Developments/Updates
Table 115. Mycenax Biotech Inc. Corporation Information
Table 116. Mycenax Biotech Inc. Description and Business Overview
Table 117. Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 118. Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Product
Table 119. Mycenax Biotech Inc. Recent Developments/Updates
Table 120. Novartis AG Corporation Information
Table 121. Novartis AG Description and Business Overview
Table 122. Novartis AG Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 123. Novartis AG Chronic Urticaria Or Hives Drug Product
Table 124. Novartis AG Recent Developments/Updates
Table 125. Panacea Biotec Limited Corporation Information
Table 126. Panacea Biotec Limited Description and Business Overview
Table 127. Panacea Biotec Limited Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 128. Panacea Biotec Limited Chronic Urticaria Or Hives Drug Product
Table 129. Panacea Biotec Limited Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Chronic Urticaria Or Hives Drug Distributors List
Table 133. Chronic Urticaria Or Hives Drug Customers List
Table 134. Chronic Urticaria Or Hives Drug Market Trends
Table 135. Chronic Urticaria Or Hives Drug Market Drivers
Table 136. Chronic Urticaria Or Hives Drug Market Challenges
Table 137. Chronic Urticaria Or Hives Drug Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Chronic Urticaria Or Hives Drug
Figure 2. Global Chronic Urticaria Or Hives Drug Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Chronic Urticaria Or Hives Drug Market Share by Type in 2022 & 2034
Figure 4. GDC-0853 Product Picture
Figure 5. GSK-2646264 Product Picture
Figure 6. BF-Derm-1 Product Picture
Figure 7. Bilastine Product Picture
Figure 8. Others Product Picture
Figure 9. Global Chronic Urticaria Or Hives Drug Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 10. Global Chronic Urticaria Or Hives Drug Market Share by Application in 2022 & 2034
Figure 11. Clinic
Figure 12. Hospital
Figure 13. Others
Figure 14. Global Chronic Urticaria Or Hives Drug Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 15. Global Chronic Urticaria Or Hives Drug Market Size (2018-2034) & (US$ Million)
Figure 16. Global Chronic Urticaria Or Hives Drug Sales (2018-2034) & (K Pcs)
Figure 17. Global Chronic Urticaria Or Hives Drug Average Price (USD/Pcs) & (2018-2034)
Figure 18. Chronic Urticaria Or Hives Drug Report Years Considered
Figure 19. Chronic Urticaria Or Hives Drug Sales Share by Manufacturers in 2022
Figure 20. Global Chronic Urticaria Or Hives Drug Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest Chronic Urticaria Or Hives Drug Players: Market Share by Revenue in 2022
Figure 22. Chronic Urticaria Or Hives Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 23. Global Chronic Urticaria Or Hives Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Figure 24. North America Chronic Urticaria Or Hives Drug Sales Market Share by Country (2018-2034)
Figure 25. North America Chronic Urticaria Or Hives Drug Revenue Market Share by Country (2018-2034)
Figure 26. U.S. Chronic Urticaria Or Hives Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 27. Canada Chronic Urticaria Or Hives Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. Europe Chronic Urticaria Or Hives Drug Sales Market Share by Country (2018-2034)
Figure 29. Europe Chronic Urticaria Or Hives Drug Revenue Market Share by Country (2018-2034)
Figure 30. Germany Chronic Urticaria Or Hives Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. France Chronic Urticaria Or Hives Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. U.K. Chronic Urticaria Or Hives Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 33. Italy Chronic Urticaria Or Hives Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. Russia Chronic Urticaria Or Hives Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. Asia Pacific Chronic Urticaria Or Hives Drug Sales Market Share by Region (2018-2034)
Figure 36. Asia Pacific Chronic Urticaria Or Hives Drug Revenue Market Share by Region (2018-2034)
Figure 37. China Chronic Urticaria Or Hives Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Japan Chronic Urticaria Or Hives Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. South Korea Chronic Urticaria Or Hives Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. India Chronic Urticaria Or Hives Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Australia Chronic Urticaria Or Hives Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Taiwan Chronic Urticaria Or Hives Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Indonesia Chronic Urticaria Or Hives Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Thailand Chronic Urticaria Or Hives Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Malaysia Chronic Urticaria Or Hives Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Philippines Chronic Urticaria Or Hives Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Latin America Chronic Urticaria Or Hives Drug Sales Market Share by Country (2018-2034)
Figure 48. Latin America Chronic Urticaria Or Hives Drug Revenue Market Share by Country (2018-2034)
Figure 49. Mexico Chronic Urticaria Or Hives Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 50. Brazil Chronic Urticaria Or Hives Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Argentina Chronic Urticaria Or Hives Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. Middle East & Africa Chronic Urticaria Or Hives Drug Sales Market Share by Country (2018-2034)
Figure 53. Middle East & Africa Chronic Urticaria Or Hives Drug Revenue Market Share by Country (2018-2034)
Figure 54. Turkey Chronic Urticaria Or Hives Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 55. Saudi Arabia Chronic Urticaria Or Hives Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 56. U.A.E Chronic Urticaria Or Hives Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 57. Global Sales Market Share of Chronic Urticaria Or Hives Drug by Type (2018-2034)
Figure 58. Global Revenue Market Share of Chronic Urticaria Or Hives Drug by Type (2018-2034)
Figure 59. Global Chronic Urticaria Or Hives Drug Price (USD/Pcs) by Type (2018-2034)
Figure 60. Global Sales Market Share of Chronic Urticaria Or Hives Drug by Application (2018-2034)
Figure 61. Global Revenue Market Share of Chronic Urticaria Or Hives Drug by Application (2018-2034)
Figure 62. Global Chronic Urticaria Or Hives Drug Price (USD/Pcs) by Application (2018-2034)
Figure 63. Chronic Urticaria Or Hives Drug Value Chain
Figure 64. Chronic Urticaria Or Hives Drug Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed